Research Article

Chromodomain Helicase DNA-Binding Protein 5 Inhibits Renal Cell Carcinoma Tumorigenesis by Activation of the p53 and RB Pathways

Figure 1

Expression of CHD5 in RCC tissues and cell lines. (a) CHD5 was downregulated in 24 RCC tumor tissues (T) compared to adjacent tissues (A). (b) CHD5 expression in TNM stage III-IV was lower than that in stage I-II. (c) CHD5 is downregulated in RCC cell lines Caki-1, 769-P, 786-0, ACHN, and A498, compared to HEK293 and HK-2. (d) Representative IHC staining with CHD5 in tumor and adjacent tissues. (e) Kaplan-Meier survival analysis assessed the correlation between CHD5 expression and overall survival. . n.s.: no significance.
(a)
(b)
(c)
(d)
(e)